Non-CME Corporate Forum sponsored by Ionis Pharmaceuticals, Inc.
Redefining Disease Control in HAE:
Challenging Clinical Decision Making to Optimize Long-Term Prophylaxis
and Improve Patient Outcomes
Friday, November 13, 2026
6:45 AM – 7:45 AM MST
Breakfast will be provided.
Sheraton Phoenix Downtown Hotel
Phoenix Ballroom Salon B (3rd Level)
340 N 3rd Street
Phoenix, AZ 85004
FACULTY
John T. Anderson, MD
Physician, Allergy and Immunology
Clinical Assistant Professor, Medicine
University of Alabama
Staff Allergist, Veteran’s Administration
Partner, AllerVie Health and Clinical Research
Birmingham, AL
Paula J. Busse, MD
Associate Professor, Department of Medicine
Division of Clinical Immunology
Icahn School of Medicine at Mount Sinai
New York, NY
What would you do better? Join this reflective case study with Drs. Paula Busse and John Anderson on hereditary angioedema. Long-term prophylaxis is redefining what disease control looks and feels like for patients and clinicians alike. Learn how to navigate this quickly evolving landscape to personalize treatment and optimize outcomes.
PROGRAM AGENDA
Paula J. Busse, MD
All Faculty
All Faculty
WHO SHOULD ATTEND?
Allergy/Immunology clinicians
LEARNING OBJECTIVES FOR ATTENDEES
Upon completion of this activity, participants should be better able to:
- Identify the unmet needs of patients living with hereditary angioedema (HAE), including challenges with long-term prophylaxis (LTP)
- Incorporate objective HAE quality-of-life (QoL) assessment tools into clinical practice
- Evaluate the impact of LTP on HAE-related outcomes, including QoL metrics
- Personalize and optimize LTP through shared decision making (SDM)
Disclosure of Financial Relationships
RMEI Medical Education, LLC (RMEI) requires instructors, planners, managers, and others in control of educational content to disclose all their financial relationships with ineligible companies over the previous 24 months. All identified financial relationships are thoroughly vetted and mitigated according to RMEI policy. RMEI will disclose to learners the presence or absence of relevant financial relationships for all persons in control of content before the learner engages in the education.
DISCLOSURE OF UNLABELED USE
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
DISCLAIMER
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.
Americans WIth Disabilities Act
Event staff will be glad to assist you with any special needs (ie, physical, dietary, etc). Please contact RMEI prior to the live event at contact@rmei.com.
The Non-CME Corporate Forum content and views expressed therein do not necessarily reflect the views, policies, or position of the American College of Allergy, Asthma & Immunology.
FEE INFORMATION
There is no fee for this educational activity.
FOLLOW RMEI
Additional educational activities offered by RMEI Medical Education, LLC can be found
at www.RMEI.com or by calling toll-free (866) 770-RMEI.